Snakebite injuries in Hong Kong: A 10‐year review
Authors:
Open Access
- 15 April 2026
- journal article
- research article
- Published by Wiley in Hong Kong Journal of Emergency Medicine
- Vol. 33 (2) , e70095
Abstract
Background: Snakebite envenomation is a priority neglected tropical disease according to the World Health Organization. To address the issue, enhanced epidemiological evidence in endemic countries and an improved availability of snake antivenoms were proposed. Objectives: To understand the local epidemiology of snakebite cases, promote awareness of potential snakebite injuries in our locality, and provide insight on the presentation and management of these injuries. Methods: An epidemiological study reviewing cases between 2012 and 2021 in our Hong Kong Poison Information Center (HKPIC) database was conducted. Snakebite cases from 1 January 2012, to 31 December 2021, were identified from the HKPIC database, by using “snake” as the poison name or category. Results: A total of 592 cases were captured, approximately 59 cases per year. The top recognised offending snake was Green Pit Viper ( Trimeresurus albolabris ) (71.8%) followed by Chinese Cobra ( Naja atra ) (3.2%), and Many‐Banded Krait ( Bungarus multicinctus ) (2.2%). Native non‐venomous or minimally venomous snakes accounted for 4.1% and pet snakes for 2.5%. Snakebites most often occur during summer and autumn, between 7 and 9PM, in rural neighborhoods. Work‐related bites accounted for 19.3% of cases. Local cytotoxicity was seen in 88%, haemotoxicity in 45.3%, and neurotoxicity in 1.5% cases. Antivenom was administered in 58.1% cases, the acute allergic reaction rate was 3.5%. Conclusions: Life‐threatening severe cytotoxicity, haemotoxicity, and neurotoxicity were observed following native snakebites in Hong Kong. GPV was the commonest observed snakebite in our locality, accounting for 71.8% cases. The general principles of prompt medical care, snake envenomation recognition, and consideration of early antivenom treatment are all critical steps in reducing snakebite mortality and morbidity.Keywords
This publication has 15 references indexed in Scilit:
- Clinical characteristics of snakebite patients attending a tertiary hospital in Hangzhou, southeast ChinaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2023
- Effect of Agkistrodon halys antivenom in patients bit by green pit viper and the prognostic role of the disease – a retrospective cohort studyClinical Toxicology, 2022
- Snakebite epidemiology in humans and domestic animals across the Terai region in Nepal: a multicluster random surveyThe Lancet Global Health, 2022
- Vulnerability to snakebite envenoming: a global mapping of hotspotsThe Lancet, 2018
- Antivenom for European Vipera species envenomingClinical Toxicology, 2017
- Clinical features and treatment experience: A review of 292 Chinese cobra snakebitesEnvironmental Toxicology and Pharmacology, 2014
- Snakebites in Hong Kong: How to Face the Possible Changes?Hong Kong Journal of Emergency Medicine, 2011
- Use of antivenom for snakebites reported to United States poison centersThe American Journal of Emergency Medicine, 2010
- Efficacy and Safety of Snake Antivenom Therapy: Experience of a Regional HospitalHong Kong Journal of Emergency Medicine, 2006
- An epidemiological study of the snake bites in the New Territories East, Hong KongPathogens and Global Health, 1994